Arvest Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.47M | Sell |
35,482
-2,691
| -7% | -$112K | 0.09% | 95 |
|
|
2024
Q1 | $2.07M | Buy |
38,173
+3,275
| +9% | +$178K | 0.12% | 91 |
|
|
2023
Q4 | $1.79M | Sell |
34,898
-8,854
| -20% | -$454K | 0.11% | 93 |
|
|
2023
Q3 | $2.54M | Sell |
43,752
-683
| -2% | -$39.6K | 0.17% | 73 |
|
|
2023
Q2 | $2.76M | Sell |
44,435
-3,139
| -7% | -$195K | 0.16% | 72 |
|
|
2023
Q1 | $3.3M | Buy |
47,574
+3,599
| +8% | +$249K | 0.21% | 68 |
|
|
2022
Q4 | $3.16M | Buy |
43,975
+3,497
| +9% | +$252K | 0.2% | 66 |
|
|
2022
Q3 | $2.88M | Buy |
40,478
+14,324
| +55% | +$1.02M | 0.2% | 65 |
|
|
2022
Q2 | $2.01M | Sell |
26,154
-2,273
| -8% | -$175K | 0.13% | 69 |
|
|
2022
Q1 | $2.08M | Buy |
28,427
+13,216
| +87% | +$965K | 0.12% | 68 |
|
|
2021
Q4 | $948K | Buy |
+15,211
| New | +$948K | 0.05% | 97 |
|